News

Last month, Purdue Pharma filed a new bankruptcy plan as part of a $7.4 billion settlement to resolve thousands of lawsuits over the company’s alleged role in the opioid crisis, after the ...
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...
The Ireland-headquartered pharma company filed for bankruptcy last year, after proposing a $1.6 billion payout to settle lawsuits claiming that its marketing of opioid painkillers helped to fuel ...
Lilly's involvement will add a new dimension to Purdue's focus on pharma manufacturing research, which was consolidated around the William D Young Institute for Advanced Manufacturing of ...
Novavax said on Wednesday U.S. regulators asked the company to produce more data on its COVID-19 vaccine if it gets full ...
2023 Solasia Pharma K.K. Registered Shs 0.00 0.00 JPY 2022 Solasia Pharma K.K. Registered Shs 0.00 0.00 JPY 2021 Solasia Pharma K.K. Registered Shs 0.00 0.00 JPY 2020 ...
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company’s products include EYLEA injection ...
Elite Pharmaceuticals ( (ELTP) ) has issued an update. Elite Pharmaceuticals announced the launch of its generic version of Vyvanse® (Lisdexamfetamine Disylate) in various strengths, targeting ...
Alnylam Pharmaceuticals, Inc. operates as biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. It is the translation of RNAi as a new ...
Drugmakers breathed a sigh of relief Wednesday after President Trump didn’t announce pharmaceutical tariffs. Plus, language in the executive order indicated medicines were exempted from the ...
GENEVA — Swiss pharmaceuticals powerhouse Roche announced ... Day” tariffs on April 2 set off turmoil in world stock markets. A week later, Trump spoke by phone with Swiss President Karin ...